DHFR-C-HiBiT
(Plasmid
#207119)
-
PurposeBacterially expressed DHFR-HiBiT for Ni-NTA purification
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 207119 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepET21a (+)
-
Backbone manufacturerEMD Biosciences (Novagen)
- Backbone size w/o insert (bp) 5443
- Total vector size (bp) 6063
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsNone
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameHuman-dihydrofolate reductase-HiBiT-10xHis
-
Alt nameHs- DHFR-HiBiT-10xHis
-
Alt nameDHFR-C-HiBiT
-
SpeciesH. sapiens (human)
-
Insert Size (bp)639
-
MutationCodon optmization for expression in BL21DE3
-
GenBank ID1719 NCBI Gene ID 1719
-
Entrez GeneDHFR (a.k.a. DHFR1, DHFRP1, DYR)
- Promoter T7
-
Tags
/ Fusion Proteins
- HiBiT tag (C terminal on insert)
- 10xHis-tag (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamH1 (unknown if destroyed)
- 3′ cloning site Hind3 (unknown if destroyed)
- 5′ sequencing primer T7 promotor primer #69348-3
- 3′ sequencing primer T7 terminator primer #69337-3 (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byDHFR-HiBiT-10xHis10 insert was synthsized for us by Bio Basic
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
DHFR-C-HiBiT was a gift from James Inglese (Addgene plasmid # 207119 ; http://n2t.net/addgene:207119 ; RRID:Addgene_207119) -
For your References section:
A general assay platform to study protein pharmacology using ligand-dependent structural dynamics. Ciulla DA, Dranchak PK, Aitha M, van Neer RHP, Shah D, Tharakan R, Wilson KM, Wang Y, Braisted JC, Inglese J. Nat Commun. 2025 May 10;16(1):4342. doi: 10.1038/s41467-025-59658-6. 10.1038/s41467-025-59658-6 PubMed 40346061